Nervonik, a medical device startup company focusing on peripheral nerve stimulation (PNS) for the treatment of chronic pain, has successfully completed the first-in-human clinical study. PNS is a rapidly growing therapy space for the multibillion-dollar chronic pain market. The Nervonik PNS device utilizes proprietary technology, originally developed in Dr. Aydin Babakhani’s laboratory

Nervonik, a medical device startup focusing on neurotechnology approaches to peripheral nerve stimulation, has received approval to conduct a first-in-human feasibility study utilizing its proprietary technology. The focus will be on chronic pain of peripheral nerve origin, although the novel technology will eventually be utilized for a variety of medical